Oncogenesis - Table of Contents alert Volume 3 Octomber 2014

Advertisement CRISPR/Cas9 monoclonal antibody now available Diagenode now offers the first monoclonal antibody against CRISPR/Cas9 Better performance that tag antibodies Validated for all major applications such as immunoblot, immunoprecipitation, and IF Recognizes Cas9 and dCas9 Learn more TABLE OF CONTENTS Volume 3, October 2014 In this issue Original Articles Short Communication Corrigendum Sign up for e-alerts Web feed Advertisement Publish your next paper in Oncogenesis    Submit your next manuscript to Oncogenesis and benefit from:      •  High visibility for your research    •  Competitive turnaround times    •  Inclusion in leading abstracting and indexing service    •  Compliance with international open access mandates   Find out more about the benefits of publishing with Oncogenesis. Original Articles Top LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6 A Ketscher, C A Jilg, D Willmann, B Hummel, A Imhof, V Rüsseler, S Hölz, E Metzger, J M Müller and R Schüle Oncogenesis 2014 3: e120; 10.1038/oncsis.2014.34 Abstract | Full Text MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death S Oka, J Leon, D Tsuchimoto, K Sakumi and Y Nakabeppu Oncogenesis 2014 3: e121; 10.1038/oncsis.2014.35 Abstract | Full Text Short Communication Top Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy D Biasoli, M F Sobrinho, A C C da Fonseca, D G de Matos, L Romão, R de Moraes Maciel, S K Rehen, V Moura-Neto, H L Borges and F R S Lima Oncogenesis 2014 3: e123; 10.1038/oncsis.2014.36 Abstract | Full Text Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance L Truitt, C Hutchinson, J F DeCoteau and C R Geyer Oncogenesis 2014 3: e122; 10.1038/oncsis.2014.37 Abstract | Full Text Corrigendum Top Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer F Al-Ejeh, P T Simpson, J M Saunus, K Klein, M Kalimutho, W Shi, M Miranda, J Kutasovic, A Raghavendra, J Madore, L Reid, L Krause, G Chenevix-Trench, S R Lakhani and K K Khanna Oncogenesis 2014 3: e124; 10.1038/oncsis.2014.41 Full Text Advertisement NEW: Discounts on lab equipment The products you need at discounted prices!  VISIT MARKETPLACE TODAY   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.